---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-000770"
form_type: "8-K"
ticker: "TENX"
cik: "0000034956"
company_name: "TENAX THERAPEUTICS, INC."
filed_at: "2024-01-19T23:59:59+00:00"
generated_at: "2026-06-06T21:33:19.956833+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tenax Therapeutics regains compliance with Nasdaq minimum bid price rule

## Summary
- Received Nasdaq written confirmation on Jan 18, 2024, after 10 consecutive trading days (Jan 3-17) closing at $1.00 or greater.
- Originally notified of bid price deficiency on March 29, 2023; later granted extension through March 25, 2024.
- Compliance achieved ahead of extension deadline; delisting risk removed.
- Bid Price Rule (Nasdaq Listing Rule 5550(a)(2)) matter now closed.

## SEC filing metadata
- accession: 0001654954-24-000770
- form_type: 8-K
- ticker: TENX
- cik: 0000034956
- company_name: TENAX THERAPEUTICS, INC.
- filed_at: 2024-01-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/34956/000165495424000770/0001654954-24-000770-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/34956/000165495424000770/tenx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-000770
- JSON: https://secwatch.observer/filing/0001654954-24-000770.json
- Plain text: https://secwatch.observer/filing/0001654954-24-000770.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.